Related Experiment Videos

Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure?

Wooseung Lee1, Peter M Kang

  • 1Beth Israel Deaconess Medical Center, Cardiovascular Division, 3 Blackfan Circle, Room 910, Boston, MA 02215, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|February 24, 2010
PubMed

Insights

Vitamin D deficiency is linked to cardiovascular disease. Vitamin D therapy shows potential benefits for heart failure patients, though its cardiac mechanisms require further study.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nutritional Science

Background:

  • Vitamin D deficiency is increasingly associated with cardiovascular disease (CVD).
  • Vitamin D supplementation may offer benefits in managing congestive heart failure (CHF).
  • The precise mechanisms of vitamin D's action within the heart remain unclear.

Purpose of the Study:

  • To review the potential mechanisms of vitamin D action in cardiac dysfunction.
  • To examine experimental and clinical evidence supporting vitamin D's role in cardiovascular disease treatment.

Main Methods:

  • Literature review of experimental studies.
  • Analysis of clinical trial data.
  • Synthesis of current research on vitamin D and cardiac health.

Main Results:

  • Evidence suggests a correlation between vitamin D deficiency and increased cardiovascular risk.
  • Vitamin D therapy demonstrates potential for improving mortality and morbidity in heart failure.
  • Further research is needed to elucidate the specific molecular pathways involved.

Conclusions:

  • Vitamin D plays a potential role in cardiovascular health and heart failure management.
  • Understanding vitamin D's mechanisms in the heart is crucial for therapeutic development.
  • Clinical studies highlight the need for further investigation into vitamin D supplementation for cardiovascular conditions.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...